This is a routine Form 3 filing for a new officer with no trading signal. Monitor future Form 4 filings for insider transactions that may provide insight into management's view of the stock.
Price Chart
Executive Summary
Nur Nicholson, newly appointed Chief Technology Officer of Kailera Therapeutics, filed a Form 3 initial statement of beneficial ownership on September 9, 2026, covering the period ending August 31, 2026. The filing is a routine administrative requirement for a new officer and includes a standard power of attorney authorizing others to file Section 16 and Form 144 documents on her behalf. No securities transactions or material financial information are disclosed.
Key Facts
- Form 3 filed by Nur Nicholson as Chief Technology Officer of Kailera Therapeutics
- Period of report: August 31, 2026; filed September 9, 2026
- Includes a power of attorney (Ex-24) for Section 16 and Form 144 filings
- No securities ownership amounts, transactions, or financial figures disclosed in the filing
Financial Impact
No financial impact — routine initial ownership filing with no disclosed holdings or transactions
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-386778 |
| Document: 0001193125-26-386778-index-headers.html | 0001193125-26-386778 |
| Document: 0001193125-26-386778-index.html | 0001193125-26-386778 |
| Document: 0001193125-26-386778.txt | 0001193125-26-386778 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access